NCT06382831

Brief Summary

Anesthesia without the use of opioid (Opioid free anesthesia) is an alternative to conventional opioid balanced anesthesia, with less post operative nausea and vomiting, and comparable analgesia. This study aim to compare the effect of opioid free versus opioid balanced anesthesia in ophthalmology surgery

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
104

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jun 2024

Shorter than P25 for phase_2

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 24, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

2 months

First QC Date

April 19, 2024

Last Update Submit

April 27, 2024

Conditions

Keywords

Opioid free anesthesiaOcular surgeryOphthalmology surgeryDexmedetomidinePost operative nausea and vomiting

Outcome Measures

Primary Outcomes (4)

  • Postoperative nausea and vomiting (PONV)

    Incidence of PONV

    24 hours

  • Pain score

    Pain score assessed with numerical rating scale (0-10) where higher value corresponds to more pain experienced by the patient

    24 hours

  • Time to laryngeal mask exertion

    Measured from the last surgical knot to LMA exertion

    Intraoperative

  • Adverse effect

    Severe changes in hemodynamics, including severe bradycardia, tachycardia, hypotension, hypertension, desaturation

    24 hours

Study Arms (2)

Control

ACTIVE COMPARATOR
Drug: Fentanyl

Opioid free anesthesia

EXPERIMENTAL
Drug: Dexmedetomidine

Interventions

Opioid free anesthesia

Opioid free anesthesia

Control given Opioid balanced anesthesia

Control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Physical status of ASA 1-2
  • Undergo elective ophthalmology surgery under general anesthesia with laryngeal mask insertion
  • BMI 17.5-34.9

You may not qualify if:

  • Allergy to study drugs
  • Baseline heart rate \< 70 beat per minute or systolic blood pressure \< 100 mmHg
  • Will undergo regional block
  • Operation lasting for \> 4 hours or \< 90 minutes
  • Consumes opioid routinely prior to operation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AgnosiaVomiting

Interventions

DexmedetomidineFentanyl

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Digestive

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPiperidines

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

April 19, 2024

First Posted

April 24, 2024

Study Start

June 1, 2024

Primary Completion

August 1, 2024

Study Completion

October 1, 2024

Last Updated

April 30, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Participants' data is kept under strict regulation by the study investigator and will not be shared without participants' consent